Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
41,068,591
-
Share change
-
+5,996,050
-
Total reported value
-
$39,454,915
-
Put/Call ratio
-
29%
-
Price per share
-
$0.96
-
Number of holders
-
100
-
Value change
-
+$5,387,289
-
Number of buys
-
51
-
Number of sells
-
31
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q4 2025
As of 31 Dec 2025,
Humacyte, Inc. - COM (HUMA) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,068,591 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, STATE STREET CORP, MORGAN STANLEY, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, BNP PARIBAS FINANCIAL MARKETS, LPL Financial LLC, and BARCLAYS PLC.
This page lists
100
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.